Signs of Active Infection with Chlamydia pneumoniae in Patients withCoronary Heart Disease
D. Hrubá; K. Roubalová 1; P. Kraml 2; M. Anděl 2
Poliklinika Černý Most – Vidia-Diagnostika s. r. o., Praha1Centrum epidemiologie a mikrobiologie SZÚ, Praha 2 II. interní klinika 3. LF UK a FNKV, Praha
Čas. Lék. čes. 2004; : 830-835
Possible relationship between Chlamydia pneumoniae (CPN) infection and atherosclerosis has beendocumented in many seroepidemiological, histological and biological studies. The objectives of the present studywere to find out whether serological signs of active CPN infection in patients with coronary heart disease (CHD)are associated with the presence of bacterial DNA in peripheral blood and to correlate with clinical symptoms andto study the dynamics of the markers of CPN infection within a six-month follow-up.Methods and Results. Seventy-one patients with acute CHD were enrolled in the study. They underwent clinicaland biochemical tests and were screened for the presence of genus- and type-specific IgG, IgA and IgM antibodiesagainst CPN at admission and then in 3- and 6-month intervals. CPN DNA was detected in peripheral blood usingnested PCR. Serological markers of active CPN infection were found in 36 patients (51.4 %) while bacterial DNAwas detected in two patients only. Laboratory signs of active CPN infection did not correlate with either clinicalsymptoms or levels of biochemical markers. In most of the patients, titers of anti-CPN antibodies were stablethroughout the follow-up. Increase in antibody titers was observed in 23 % of patients and was associated with morefrequent signs of unstable angina pectoris (p=0,06) but not with higher risk of myocardial infarction within 6 monthsafter the acute episode of CHD.Conclusions. In patients with CHD, serological markers of active infection persist for a long time. Nevertheless,their association with the course of CHD or relapse risk was not proved. Bacterial DNA was rarely detected inperipheral blood of the patients. None of the currently available laboratory tests proved adequately effective fordetection of ongoing or chronic CPN infection. This project was sponsored by grant IGA MZ ČR NI/6811-3 andresearch plan of Natl. Inst.Publ.Health
Chlamydia pneumoniae, antibodies, PCR, coronary heart disease, atherosclerosis.
Full text is not available online.
If interested in a scan of this journal, contact NTO ČLS JEP
Allergology and clinical immunology
Dermatology & STDs